{"id":"W4379339089","doi":"10.1200/jco.2023.41.16_suppl.7545","title":"Zanubrutinib plus obinutuzumab versus obinutuzumab in patients with relapsed/refractory follicular lymphoma: Updated analysis of the ROSEWOOD study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"BeiGene","keywords":"Medicine; Obinutuzumab; Internal medicine; Follicular lymphoma; Rituximab; Clinical endpoint; International Prognostic Index; Oncology; Refractory (planetary science); Progression-free survival; Neutropenia; Salvage therapy; Surgery; Gastroenterology; Chemotherapy; Lymphoma; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004535384,0.0005505069,0.00153414,0.0005126858,0.0001348599,0.0008563742,0.0006994445,0.0003820125,0.001622802],"category_scores_gemma":[0.00236654,0.0002652609,0.002292205,0.0009272653,0.0002370926,0.0005579224,0.00041055,0.00092119,0.0002120005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006582444,"about_ca_system_score_gemma":0.0006252066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001489551,"about_ca_topic_score_gemma":0.005059324,"domain_scores_codex":[0.9986975,0.0007455224,0.0001067546,0.000158659,0.0002012741,0.00009030242],"domain_scores_gemma":[0.9983724,0.0005746671,0.0006308759,0.0001327374,0.0001045168,0.0001848659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4292368,0.001560176,0.2037376,0.005089927,0.05290914,0.0003858779,0.0003119146,0.003548782,0.01037769,0.0006137294,0.01195496,0.2802733],"study_design_scores_gemma":[0.1802401,0.04841714,0.6450623,0.0007941781,0.08611672,0.001479256,0.0001889405,0.003574833,0.002444164,0.0006412817,0.03091946,0.0001216733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9176302,0.0704274,0.0008113011,0.0008228854,0.0001284179,0.0006245191,0.00543529,0.00006528851,0.004054765],"genre_scores_gemma":[0.9799228,0.0116524,0.001113113,0.0007918393,0.0002434638,0.0002876447,0.005166288,0.00002290406,0.0007994468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004535384,"threshold_uncertainty_score":0.02398574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0636855480645238,"score_gpt":0.3946122477324434,"score_spread":0.3309266996679196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}